HK Stock Market Move | SCIENTECH (02291) surged more than 14% at the close. MemoSorb ASD/VSD occluder has obtained a market approval in Saudi Arabia.

SCIENTECH (02291) surged more than 14% at the close, with a cumulative increase of over 35% for the month. As of the time of writing, it rose by 11.66% to 13.6 Hong Kong dollars, with a turnover of 40.9436 million Hong Kong dollars. On the news front, in July of this year, the MemoSorb biodegradable atrial septal defect (ASD) occluder and fully degradable ventricular septal defect (VSD) occluder developed independently by SCIENTECH were approved for listing in the Saudi Arabian medical device market. It is worth noting that in April of this year, the biodegradable patent foramen ovale (PFO) occluder and transcatheter aortic valve replacement (TAVR) system have already been approved for listing in Saudi Arabia. With this, SCIENTECH has fully implemented the structural heart disease solution system in the Middle East market based on the MemoSorb PFO/ASD/VSD occluder matrix + ScienCrown TAVR system, gaining recognition from overseas authorities, laying a solid foundation for future clinical applications in the Middle East region, and serving more cardiovascular disease patients worldwide.